about
sameAs
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disordersA model of gene-gene and gene-environment interactions and its implications for targeting environmental interventions by genotypePharmacogenetics and pharmacogenomicsIdentifying future models for delivering genetic services: a nominal group study in primary carePolymorphisms of the Flavin containing monooxygenase 3 (FMO3) gene do not predispose to essential hypertension in CaucasiansWill nicotine genetics and a nicotine vaccine prevent cigarette smoking and smoking-related diseases?The genetics of tobacco use: methods, findings and policy implicationsThe path from genome-based research to population health: development of an international public health genomics networkAdvanced sequencing technologies: methods and goalsPragmatic medicine in solid cancer: a translational alternative to precision medicinePlanning for translational research in genomicsA research agenda for assessing the potential contribution of genomic medicine to tobacco control.Reclassification of genetic-based risk predictions as GWAS data accumulate.Patient accounts of diagnostic testing for familial hypercholesterolaemia: comparing responses to genetic and non-genetic testing methods.The Nod2 gene in Crohn's disease: implications for future research into the genetics and immunology of Crohn's disease.Genetic-based prediction of disease traits: prediction is very difficult, especially about the futureThe challenge of integrating genetic medicine into primary care.Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes2000 ASHG Award for Excellence in Education. Resetting our educational sights: unconstructing the public's dreams and nightmares of the genetic revolutionSudden infant death syndrome and other causes of infant mortality: diagnosis, mechanisms, and risk for recurrence in siblings.Genetics and social classGenome-based prediction of common diseases: advances and prospects.Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease risk.Integration of genetics into clinical teaching in medical school education.Pharmacogenomics of primary hypertension--the lessons from the past to look toward the future.Pharmacogenomics: implications and considerations for pharmacists.Evidence and the future of medicine.Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease.Genetics and public health--evolution, or revolution?Newborn screening: new developments, new dilemmas.Obesity--is it a genetic disorder?The use of gene tests to detect hereditary predisposition to chronic disease: is cost-effectiveness analysis relevant?TCF7L2: the biggest story in diabetes genetics since HLA?Provision of genetic services in Europe: current practices and issues.Coronary risk in relation to genetic variation in MEOX2 and TCF15 in a Flemish populationProspects of genetic research of mild cognitive impairment.Ethics and research assessing the relative roles of genes and the environment.Measuring the value of pharmacogenomics.Modern cancer epidemiological research: genetic polymorphisms and environment.Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking.
P2860
Q22330767-CC84FD91-DCC8-4AAC-9B12-C969E8AA5C92Q24288935-30386AEC-1AFB-46F4-9878-99396516D496Q24564983-04B79E4C-D578-4174-879F-3114BCF23F6EQ24792925-B0F2E0EA-0A93-4F9A-9147-269BB7AC00DEQ24813080-A9992639-590A-46C7-BE85-5063B7E2DE8EQ24816319-D6795713-CA5A-4C24-9FCD-FC76A9454371Q28201220-F2626EE9-7A2B-4B17-A717-13CC5749D8B7Q28252405-8BEBD7F3-BB69-4686-B6AB-4ECB069D57DDQ28261786-A2B6CCCE-8704-4C24-831B-22331E6BC406Q28391863-D3F88FD4-3811-4257-8E02-B6519B15966FQ28750341-4E6A8CA4-D339-4DFF-955F-3E558E8AAF01Q30230101-0FB8CF15-673B-47F6-86B0-BC5788E08D5AQ31046674-4AC93D45-BA47-4173-A077-5CA2BAB3D06BQ31096111-F4334649-40E7-41A5-8F1D-DC3859CD0822Q33335841-AC78DDE0-A9CB-4B4E-B815-91A4D2609EC2Q33693846-5F71D6F6-06F6-4DE8-ACEA-CE6FE5F003A3Q33805196-9D3528FD-2EF2-44D7-8529-3DC82DBE4FCEQ33904517-E24DE800-D288-4E44-8CB2-93AF42D86817Q34114626-25EB9B14-C347-4F2F-B569-C1AD05764900Q34334114-CB25D5B4-3403-4442-A237-03518D791907Q34702238-7059E1AB-2C66-4974-9EE9-CB9C64875D4EQ34851798-06AA27E2-E19E-4326-8466-BA3E1AEB312FQ34988777-F4696549-20B1-4C27-BC5D-28F119BD860EQ35051962-B9C690F5-A131-48D5-93FC-3B48543DEBEAQ35116095-ED74698A-9DFD-4D91-BED8-F702B1E12E66Q35116109-1AF8A140-B7C9-4E41-AEC5-5409F81E9A81Q35146753-FC1D568E-83E8-48D3-9C4F-25A0ACA298D5Q35179023-77E468F8-B41A-41F6-94B6-2E141B8BDC6CQ35413524-F6014EFE-3A94-40EC-854C-3475E8BC0DFAQ35430126-72B27C48-9BB7-4D67-BB54-D6752BB67921Q35555011-C76A5559-8043-48B7-A01A-C8D0EB639062Q35564692-FD7C323B-0448-4B7B-9057-8EF0FBF73F31Q35566632-2E80C54D-05AF-4EFC-9393-B24224D75403Q35626852-BA280EE3-6FE2-4ADB-ACC1-186BB847E28AQ35795828-F5A3ED2C-26C0-43FB-9FDB-A515FF636283Q35868494-52ED9C60-F894-4368-9AF9-81CB1568EC82Q36090392-289AFC00-9E06-4914-97D3-27B5934D059CQ36138347-116D5378-F719-45DA-AD93-CF64EA2D9343Q36183829-55B9F0BE-F8C5-4E7D-8CA6-E40054EA84D7Q36203479-796F48A9-EBA3-4DDE-A9B9-1457072EAB5C
P2860
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Will Genetics Revolutionize Medicine?
@en
Will Genetics Revolutionize Medicine?
@nl
type
label
Will Genetics Revolutionize Medicine?
@en
Will Genetics Revolutionize Medicine?
@nl
prefLabel
Will Genetics Revolutionize Medicine?
@en
Will Genetics Revolutionize Medicine?
@nl
P1476
Will genetics revolutionize medicine?
@en
P2093
Holtzman NA
P304
P356
10.1056/NEJM200007133430213
P407
P577
2000-07-01T00:00:00Z